Myasthenia gravis drugs

These companies make drugs for myasthenia gravis and similar diseases where antibodies attack nerves.
+19.8%
over 1 month · S&P 500 −2.3%

Key indicators

Health
53 / 100
Fragile
Solid
Up over 1 year
6 of 7
Volatility
60%
Calm
Choppy
Profitability
−42%
Low
High
Health and price: against the other tags.